Sei Investments CO Incyte Corp Transaction History

Sei Investments CO

$66.7 Billion
Q1 2024

A detailed history of Sei Investments CO transactions in Incyte Corp stock. As of the latest transaction made, Sei Investments CO holds 205,116 shares of INCY stock, worth $12.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

205,116

Previous 204,927 0.09%

Holding current value

$12.1 Million

Previous $12.9 Million 9.19%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$56.55 - $66.59 $10,687 - $12,585	189 Added 0.09%	205,116 $11.7 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $896,265 - $1.1 Million	17,183 Added 9.15%	204,927 $12.9 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $2.96 Million - $3.37 Million	51,170 Added 37.47%	187,744 $10.8 Million
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $673,009 - $833,781	-11,042 Reduced 7.48%	136,574 $8.5 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $759,396 - $930,026	10,813 Added 7.9%	147,616 $10.7 Million

Q4 2022 Feb 10, 2023	BUY	$67.18 - $84.11 $1.65 Million - $2.06 Million	24,504 Added 21.82%	136,803 $11 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $2.19 Million - $2.74 Million	33,043 Added 41.69%	112,299 $7.49 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $158,501 - $199,216	2,395 Added 3.12%	79,256 $6 Million
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $571,865 - $690,448	8,662 Added 12.7%	76,861 $6.1 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $423,681 - $495,721	6,689 Added 10.87%	68,199 $5 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $357,702 - $437,660	5,209 Added 9.25%	61,510 $4.23 Million
Q2 2021 Aug 06, 2021	BUY	$79.87 - $87.53 $2.31 Million - $2.53 Million	28,875 Added 105.28%	56,301 $4.75 Million
Q1 2021 May 12, 2021	BUY	$76.02 - $100.5 $433,314 - $572,850	5,700 Added 26.24%	27,426 $2.26 Million
Q4 2020 Feb 08, 2021	SELL	$80.74 - $97.7 $1.28 Million - $1.55 Million	-15,830 Reduced 42.15%	21,726 $1.91 Million
Q3 2020 Dec 04, 2020	SELL	$85.07 - $109.69 $100,637 - $129,763	-1,183 Reduced 3.05%	37,556 $3.49 Million
Q3 2020 Nov 06, 2020	BUY	$85.07 - $109.69 $244,406 - $315,139	2,873 Added 8.01%	38,739 $3.6 Million
Q2 2020 Aug 17, 2020	SELL	$74.18 - $108.93 $6.33 Million - $9.3 Million	-85,383 Reduced 70.42%	35,866 $3.77 Million
Q2 2020 Aug 11, 2020	BUY	$74.18 - $108.93 $1.47 Million - $2.16 Million	19,812 Added 19.53%	121,249 $10.9 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $1.14 Million - $1.56 Million	-18,104 Reduced 15.14%	101,437 $7.43 Million
Q4 2019 Feb 06, 2020	BUY	$73.04 - $95.72 $1.18 Million - $1.55 Million	16,218 Added 15.7%	119,541 $10.4 Million
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $4.15 Million - $4.93 Million	57,022 Added 123.16%	103,323 $7.68 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $584,336 - $704,987	7,948 Added 20.72%	46,301 $3.93 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $2.44 Million - $3.38 Million	38,353 New	38,353 $3.3 Million
Q3 2018 Nov 08, 2018	SELL	$61.75 - $74.23 $920,754 - $1.11 Million	-14,911 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$60.85 - $83.98 $333,944 - $460,882	5,488 Added 58.24%	14,911 $999,000
Q1 2018 May 11, 2018	SELL	$83.06 - $100.98 $1.35 Million - $1.64 Million	-16,256 Reduced 63.3%	9,423 $785,000
Q4 2017 Feb 08, 2018	SELL	$93.56 - $116.6 $1.6 Million - $1.99 Million	-17,065 Reduced 39.92%	25,679 $2.43 Million
Q3 2017 Nov 06, 2017	BUY	$109.15 - $138.27 $4.67 Million - $5.91 Million	42,744	42,744 $4.99 Million

Others Institutions Holding INCY

# of Institutions

617

Shares Held

215M

Call Options Held

366K

Put Options Held

445K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Incyte Corp Transaction History